Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $664.58 | 32 | 98.2% |
| Education | $12.19 | 1 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $70.45 | 3 | $0 (2020) |
| JAZZ PHARMACEUTICALS INC. | $62.60 | 2 | $0 (2021) |
| Dexcom, Inc. | $56.72 | 2 | $0 (2024) |
| Eisai Inc. | $41.19 | 2 | $0 (2020) |
| Gilead Sciences, Inc. | $36.31 | 2 | $0 (2019) |
| GlaxoSmithKline, LLC. | $34.48 | 2 | $0 (2023) |
| Pharmacyclics LLC, An AbbVie Company | $34.00 | 2 | $0 (2019) |
| Abbott Laboratories | $27.67 | 2 | $0 (2022) |
| Seagen Inc. | $27.65 | 1 | $0 (2020) |
| Agios Pharmaceuticals, Inc. | $25.20 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $56.72 | 2 | Dexcom, Inc. ($56.72) |
| 2023 | $34.48 | 2 | GlaxoSmithKline, LLC. ($34.48) |
| 2022 | $31.45 | 2 | Boston Scientific Corporation ($19.81) |
| 2021 | $33.83 | 1 | JAZZ PHARMACEUTICALS INC. ($33.83) |
| 2020 | $142.82 | 7 | E.R. Squibb & Sons, L.L.C. ($50.33) |
| 2019 | $128.89 | 6 | JAZZ PHARMACEUTICALS INC. ($28.77) |
| 2018 | $169.07 | 9 | Takeda Pharmaceuticals U.S.A., Inc. ($21.77) |
| 2017 | $79.51 | 4 | Eisai Inc. ($23.67) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 2 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/16/2018 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Oncology | ||||||
| 03/19/2018 | Genentech USA, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: BioOncology | ||||||
| 02/19/2018 | Amgen Inc. | Prolia (Biological), XGEVA | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Endocrinology | ||||||
| 01/29/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: ONCOLOGY | ||||||
| 07/17/2017 | E.R. Squibb & Sons, L.L.C. | EMPLICITI (Biological) | Food and Beverage | Cash or cash equivalent | $20.12 | General |
| Category: Oncology | ||||||
| 03/20/2017 | Eisai Inc. | Halaven (Drug) | Food and Beverage | Cash or cash equivalent | $23.67 | General |
| Category: Oncology | ||||||
| 02/27/2017 | Millennium Pharmaceuticals, Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Oncology | ||||||
| 02/09/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $12.93 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 23 | 721 | 944 | $91,350 | $19,506 |
| 2020 | 62 | 3,671 | 31,745 | $2.1M | $505,010 |
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Office | 2021 | 17 | 41 | $6,560 | $6,563 | 100.0% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 27 | 28 | $19,796 | $3,353 | 16.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 97 | 97 | $24,250 | $2,692 | 11.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 96 | 107 | $6,848 | $1,112 | 16.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 100 | 112 | $4,032 | $857.02 | 21.3% |
| 96367 | Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | Office | 2021 | 18 | 27 | $4,239 | $679.97 | 16.0% |
| 85055 | Reticulated (young) platelet measurement | Office | 2021 | 16 | 16 | $2,288 | $571.84 | 25.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 11 | 11 | $3,443 | $503.91 | 14.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 117 | 133 | $2,660 | $390.00 | 14.7% |
| 83520 | Measurement of substance using immunoassay technique | Office | 2021 | 11 | 22 | $3,982 | $379.94 | 9.5% |
| 86300 | Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | Office | 2021 | 16 | 18 | $2,304 | $374.58 | 16.3% |
| 82728 | Ferritin (blood protein) level | Office | 2021 | 25 | 27 | $1,620 | $368.01 | 22.7% |
| 86320 | Immunologic analysis technique on serum | Office | 2021 | 11 | 11 | $1,188 | $329.12 | 27.7% |
| 86334 | Immunologic analysis technique on serum (immunofixation) | Office | 2021 | 11 | 11 | $1,760 | $245.74 | 14.0% |
| 83550 | Iron binding capacity | Office | 2021 | 24 | 26 | $910.00 | $227.24 | 25.0% |
| 83540 | Iron level | Office | 2021 | 24 | 26 | $702.00 | $168.22 | 24.0% |
| 84165 | Protein measurement, serum | Office | 2021 | 13 | 14 | $1,386 | $154.52 | 11.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 12 | 13 | $1,248 | $153.40 | 12.3% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2021 | 18 | 22 | $682.00 | $132.88 | 19.5% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2021 | 15 | 17 | $578.00 | $109.99 | 19.0% |
| 85007 | Microscopic examination for white blood cells with manual cell count | Office | 2021 | 15 | 17 | $374.00 | $64.60 | 17.3% |
| 85045 | Red blood count, automated test | Office | 2021 | 14 | 16 | $368.00 | $63.84 | 17.3% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2021 | 13 | 132 | $132.00 | $12.09 | 9.2% |
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2020 | 11 | 3,600 | $441,200 | $143,257 | 32.5% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Office | 2020 | 68 | 441 | $70,560 | $70,054 | 99.3% |
About Dr. Jerry Fain, M.D
Dr. Jerry Fain, M.D is a Hematology & Oncology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447293840.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jerry Fain, M.D has received a total of $676.77 in payments from pharmaceutical and medical device companies, with $56.72 received in 2024. These payments were reported across 33 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($664.58).
As a Medicare-enrolled provider, Fain has provided services to 4,392 Medicare beneficiaries, totaling 32,689 services with total Medicare billing of $524,516. Data is available for 2 years (2020–2021), covering 85 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Austin, TX
- Active Since 06/14/2006
- Last Updated 01/13/2009
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1447293840
Products in Payments
- VYXEOS (Drug) $62.60
- Dexcom G6 Transmitter (Medical Supply) $56.72
- NINLARO (Drug) $44.56
- OPDIVO (Biological) $38.14
- AREXVY (Drug) $34.48
- Imbruvica (Drug) $34.00
- PADCEV (Biological) $27.65
- TIBSOVO (Drug) $25.20
- Halaven (Drug) $23.67
- TECENTRIQ (Biological) $21.54
- ADCETRIS (Biological) $21.21
- EMPLICITI (Biological) $20.12
- TheraSphere Y90 Glass Microspheres 10 GBq (Device) $19.81
- Venclexta (Drug) $19.50
- Prolia (Biological) $19.17
- Lonsurf (Drug) $18.88
- LIBTAYO (Biological) $17.70
- RETEVMO (Drug) $17.60
- Lenvima (Drug) $17.52
- Axium INS DRG IPG (Device) $16.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Austin
Dr. Debra Patt, Md, Mph, MD, MPH
Hematology & Oncology — Payments: $109,909
Uttam Rao
Hematology & Oncology — Payments: $19,966
Dr. Allison Gorrebeeck, Md, MD
Hematology & Oncology — Payments: $5,624
Dr. Richard Helmer, M.d, M.D
Hematology & Oncology — Payments: $3,540
Vinod Kondragunta
Hematology & Oncology — Payments: $3,490
Dr. Shubhada Shrikhande, Md, MD
Hematology & Oncology — Payments: $1,469